Schizophrenia: a multisystem disease? - Test2 - elhamkhani - TriplyDB

Schizophrenia: a multisystem disease?

Schizophrenia: a multisystem disease?

http://www.wikidata.org/entity/Q24633845

about

Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes.Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia.A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications.Neurobiological effects of physical exercise in schizophrenia: a systematic review.Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.Associations among comorbid anxiety, psychiatric symptomatology, and diabetic control in a population with serious mental illness and diabetes: Findings from an interventional randomized controlled trial.Metabolic Syndrome among Schizophrenic Patients: A Comparative Cross-Sectional Study in the Middle Belt of Ghana

P2860

Q35811392-12CA5751-A6E2-4280-97FE-4C7A2019E2E3 Q36424084-E43683D1-0649-4515-814F-D407BA6DA50A Q37231225-EB4CE344-8935-493B-AB38-B8AA9FE94350 Q37998841-9D72CC6A-8C8A-49B2-B392-5361E19D89DF Q38175169-36575693-0DBD-4ABE-B3EC-3484581B346A Q42251217-81ADDF29-F1A0-4724-8887-4F1943CC210D Q47244549-AB5AF560-4CED-42A4-9A17-7BB70D184866 Q58969472-074F4838-3FF7-4D54-BFED-4EA08A209F65

P2860

Schizophrenia: a multisystem disease?

http://www.wikidata.org/entity/Q24633845

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Schizophrenia: a multisystem disease?

@ast

Schizophrenia: a multisystem disease?

@en

Schizophrenia: a multisystem disease?

@nl

type

label

Schizophrenia: a multisystem disease?

@ast

Schizophrenia: a multisystem disease?

@en

Schizophrenia: a multisystem disease?

@nl

prefLabel

Schizophrenia: a multisystem disease?

@ast

Schizophrenia: a multisystem disease?

@en

Schizophrenia: a multisystem disease?

@nl

P1433

Q24633845-EB5E9A16-3F1E-4B9D-9968-5E6AF6068D42

P1476

Q24633845-F4FE68B6-D175-43B8-AD83-B602A6EC7833

P2093

Q24633845-95DD9FFE-E37E-4C27-BFB0-9212376BAC86

P2860

Q24633845-08A6C09B-6FFB-4D53-8C25-E3EC68C812F1

Q24633845-0F2CF341-38AB-46A0-9E0E-FEA6E6A37EB5

Q24633845-144C8061-9305-4C1E-9DC3-1B865E134A19

Q24633845-185D0E70-BA9F-4A7E-AD5C-13137F962B8C

Q24633845-1ABD22F4-1A5A-48E1-851A-54E82E000199

Q24633845-2E94DEEE-7047-4E89-A57A-BC4F9B111693

Q24633845-37FFF7BA-110D-4B04-8F24-6F42097A7AA9

Q24633845-484FAA60-9817-473F-944E-404F6C1853ED

Q24633845-4B3F6F4D-2CD3-4994-8F3A-B9DD4D5CB8EB

Q24633845-5A20CCEB-9C52-48B3-83AF-7EB5F8B687B6

P304

Q24633845-8D9EE7DE-4D2B-4205-AB4F-56F183599669

P31

Q24633845-C8A206D0-7B07-426C-8DCD-E5E2689BF8EA

Q24633845-f19216f0-9f2e-45b8-98a2-c54e2dd6cad7

P356

Q24633845-41E44266-C036-4531-AA07-3772635C3248

P407

Q24633845-D32A6ECE-458D-40E4-94F1-8E8F87209B42

P433

Q24633845-4918F6CE-F41D-4A72-AE14-EF4ABBC8ADC9

P478

Q24633845-73E3A95C-E0A7-4A05-9465-BDFDA4CF035A

P50

Q24633845-4954576C-E4AA-4CEC-A9BF-1C25903497D7

P577

Q24633845-31FE62DA-7175-42FB-8D4C-F3031BEDEB5A

P5875

Q24633845-C358CF10-1EBA-4EEB-AF12-29AE0DE3AA21

P698

Q24633845-96E934DD-637B-490E-9723-02E4B9BB84CA

P921

Q24633845-750C8B2A-4DC4-461C-A15F-20E7A6483AE0

P932

Q24633845-165BC7DE-6664-4B24-8E10-4107010122AA

P356

1359786810382059

P1433

Journal of Psychopharmacology

P1476

Schizophrenia: a multisystem disease?

@en

P2093

Timothy G Dinan

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness

Schizophrenia, neuroleptic medication and mortality.

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

Schizophrenia and increased risks of cardiovascular disease.

Physical health and schizophrenia.

Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Metabolic syndrome in people with schizophrenia: a review.

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis.

Metabolic profile of antipsychotic-naive individuals with non-affective psychosis

P304

5-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1359786810382059

http://www.w3.org/2001/XMLSchema#string

P407

P433

4 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Alex J. Mitchell

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47412794

http://www.w3.org/2001/XMLSchema#string

P698

20923915

http://www.w3.org/2001/XMLSchema#string

P921

P932

2951587

http://www.w3.org/2001/XMLSchema#string